|
Snyder, Michelle L; Shields, Kelly J; Korytkowski, Mary T et al. (2014) Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls. Gynecol Endocrinol 30:511-5
|
|
Talbott, Evelyn O; Zborowski, Jeanne; Rager, Judy et al. (2008) Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? Vasc Health Risk Manag 4:453-62
|
|
Talbott, Evelyn O; Zborowski, Jeanne V; Rager, Judith R et al. (2007) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women. J Womens Health (Larchmt) 16:191-7
|
|
Talbott, E O; Zborowski, J V; Boudreaux, M Y et al. (2004) The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:6061-7
|
|
Winters, S J; Talbott, E; Guzick, D S et al. (2000) Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril 73:724-9
|
|
Talbott, E O; Guzick, D S; Sutton-Tyrrell, K et al. (2000) Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-21
|
|
Guzick, D S; Talbott, E O; Sutton-Tyrrell, K et al. (1996) Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol 174:1224-9;discussion 1229-32
|
